Health ❯Obesity

Weight Loss Treatments

GLP-1 Agonists Pharmaceuticals GLP-1 Receptor Agonists GLP-1 Drugs Zepbound Wegovy Prescription Drugs Medications Clinical Research Drug Efficacy Pharmaceutical Interventions Clinical Trials

Novo Nordisk Faces Investor Concerns as Wegovy Sales Stagnate and Competition Intensifies

Shares drop 25% in March, with compounded drugs and Eli Lilly's Zepbound challenging market dominance.

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss